Solid Biosciences Inc.
(NASDAQ : SLDB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.09%203.001.2%$406.48m
GILDGilead Sciences, Inc.
0.51%73.150.9%$396.47m
CELGCelgene Corporation
0.67%87.781.2%$341.39m
BIIBBiogen Inc.
0.25%335.251.2%$274.66m
ILMNIllumina, Inc.
1.42%352.163.5%$255.83m
REGNRegeneron Pharmaceuticals, Inc.
-0.14%385.972.6%$209.96m
EXASExact Sciences Corporation
-1.79%72.0225.3%$195.13m
VRTXVertex Pharmaceuticals Incorporated
0.59%176.831.9%$160.81m
SRPTSarepta Therapeutics, Inc.
0.93%153.7616.4%$126.02m
AAgilent Technologies, Inc.
-0.51%68.731.5%$120.88m
ALXNAlexion Pharmaceuticals, Inc.
1.51%119.592.0%$109.12m
NKTRNektar Therapeutics
0.57%58.645.6%$96.51m
ALNYAlnylam Pharmaceuticals, Inc
0.42%93.759.7%$96.22m
BMRNBioMarin Pharmaceutical Inc.
1.00%99.134.4%$91.59m
INCYIncyte Corporation
0.73%67.512.5%$88.35m

Company Profile

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey Zarur, and Gilad Hayeem in March 2013 and is headquartered in Cambridge, MA.